Sun Pharmaceutical Industries Limited SUNPHARMA.NS Stock
Sun Pharmaceutical Industries Limited Price Chart
Sun Pharmaceutical Industries Limited SUNPHARMA.NS Financial and Trading Overview
Contents
Sun Pharmaceutical Industries Limited stock price | 1519.2 INR |
Previous Close | 988.4 INR |
Open | 990 INR |
Bid | 990.2 INR x 0 |
Ask | 990.4 INR x 0 |
Day's Range | 987.2 - 992.65 INR |
52 Week Range | 789.9 - 1072.15 INR |
Volume | 2.09M INR |
Avg. Volume | 2.39M INR |
Market Cap | 2.38T INR |
Beta (5Y Monthly) | 0.370205 |
PE Ratio (TTM) | 28.035109 |
EPS (TTM) | 37.11 INR |
Forward Dividend & Yield | 10.5 (1.06%) |
Ex-Dividend Date | February 8, 2023 |
1y Target Est | 829.22 INR |
SUNPHARMA.NS Valuation Measures
Enterprise Value | 2.31T INR |
Trailing P/E | 28.035109 |
Forward P/E | 30.299877 |
PEG Ratio (5 yr expected) | 0.83 |
Price/Sales (ttm) | 5.4136486 |
Price/Book (mrq) | 4.2280283 |
Enterprise Value/Revenue | 5.263 |
Enterprise Value/EBITDA | 19.619 |
Trading Information
Sun Pharmaceutical Industries Limited Stock Price History
Beta (5Y Monthly) | 0.370205 |
52-Week Change | 24.57% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1072.15 INR |
52 Week Low | 789.9 INR |
50-Day Moving Average | 976.94 INR |
200-Day Moving Average | 985.55 INR |
SUNPHARMA.NS Share Statistics
Avg. Volume (3 month) | 2.39M INR |
Avg. Daily Volume (10-Days) | 2.42M INR |
Shares Outstanding | 2.4B |
Float | 1.03B |
Short Ratio | N/A |
% Held by Insiders | 12.35% |
% Held by Institutions | 26.62% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 11.5 |
Trailing Annual Dividend Yield | 1.16% |
5 Year Average Dividend Yield | 85.00% |
Payout Ratio | 0.2975 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 19.30% |
Operating Margin (ttm) | 21.06% |
Gross Margin | 75.70% |
EBITDA Margin | 26.82% |
Management Effectiveness
Return on Assets (ttm) | 7.67% |
Return on Equity (ttm) | 15.42% |
Income Statement
Revenue (ttm) | 438.86B INR |
Revenue Per Share (ttm) | 182.82 INR |
Quarterly Revenue Growth (yoy) | 15.69% |
Gross Profit (ttm) | 332.24B INR |
EBITDA | 117.73B INR |
Net Income Avi to Common (ttm) | 84.74B INR |
Diluted EPS (ttm) | 35.32 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 151.43B INR |
Total Cash Per Share (mrq) | 63.34 INR |
Total Debt (mrq) | 68.86B INR |
Total Debt/Equity (mrq) | 11.61 INR |
Current Ratio (mrq) | 2.003 |
Book Value Per Share (mrq) | 234.199 |
Cash Flow Statement
Operating Cash Flow (ttm) | 49.59B INR |
Levered Free Cash Flow (ttm) | 9.22B INR |
Profile of Sun Pharmaceutical Industries Limited
Country | India |
State | N/A |
City | Mumbai |
Address | Sun House |
ZIP | 400063 |
Phone | 91 22 4324 4324 |
Website | https://www.sunpharma.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.
Q&A For Sun Pharmaceutical Industries Limited Stock
What is a current SUNPHARMA.NS stock price?
Sun Pharmaceutical Industries Limited SUNPHARMA.NS stock price today per share is 1519.2 INR.
How to purchase Sun Pharmaceutical Industries Limited stock?
You can buy SUNPHARMA.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sun Pharmaceutical Industries Limited?
The stock symbol or ticker of Sun Pharmaceutical Industries Limited is SUNPHARMA.NS.
Which industry does the Sun Pharmaceutical Industries Limited company belong to?
The Sun Pharmaceutical Industries Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Sun Pharmaceutical Industries Limited have in circulation?
The max supply of Sun Pharmaceutical Industries Limited shares is 2.4B.
What is Sun Pharmaceutical Industries Limited Price to Earnings Ratio (PE Ratio)?
Sun Pharmaceutical Industries Limited PE Ratio is 41.02667600 now.
What was Sun Pharmaceutical Industries Limited earnings per share over the trailing 12 months (TTM)?
Sun Pharmaceutical Industries Limited EPS is 37.11 INR over the trailing 12 months.
Which sector does the Sun Pharmaceutical Industries Limited company belong to?
The Sun Pharmaceutical Industries Limited sector is Healthcare.
Sun Pharmaceutical Industries Limited SUNPHARMA.NS included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NIFTY 50 NSEI | 22315.6 INR 269.98 USD |
-0.91
|
— — | 22302.5 INR 269.82 USD | 22373.55 INR 270.68 USD | — - | — — |
S&P BSE SENSEX BSESN | 73670.04 INR 891.28 USD |
-0.77
|
— — | 73315.16 INR 886.99 USD | 73715.87 INR 891.84 USD | — - | — — |
Nasdaq EM Plus Korea Large Cap NQEMKRLCGBPN | 1820.04 GBP 2327.71 USD |
<0.01
|
— — | 1820.04 GBP 2327.71 USD | 1820.04 GBP 2327.71 USD | — - | — — |
- {{ link.label }} {{link}}